Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Patients With Chronic Pelvic Pain With Vaginal Microbiota

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03786588
Recruitment Status : Unknown
Verified August 2019 by shuwang, Peking Union Medical College Hospital.
Recruitment status was:  Recruiting
First Posted : December 26, 2018
Last Update Posted : August 29, 2019
Sponsor:
Information provided by (Responsible Party):
shuwang, Peking Union Medical College Hospital

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Vaginal microorganisms play an important role in the occurrence and development of many diseases, such as persistent infection of high-risk human papillomavirus (HR-HPV) causing cervical intraepithelial neoplasia and cervical cancer, and the role of microorganisms in chronic prostatitis.

Condition or disease Intervention/treatment
Pelvic Pain Other: Observation

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 1 participants
Observational Model: Case-Control
Time Perspective: Prospective
Target Follow-Up Duration: 1 Year
Official Title: Chronic Pelvic Pain With Vaginal Microbiota in Gestational Women Without HPV Infection
Actual Study Start Date : December 25, 2018
Estimated Primary Completion Date : December 25, 2019
Estimated Study Completion Date : December 25, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pelvic Pain

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Group A
Vaginal microbiota in gestation CPP women without HPV infection
 Other: Observation
The patients with the negative results of HPV infection, and assigned to different group according to the CPP manifestation.
GroupB
Vaginal microbiota in gestation women without CPP and HPV infection


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Vaginal microbiota difference [ Time Frame: one year ]
    Vaginal microbiota difference between the women with or without CPP, and all the cases are cervical HPV negative.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Male
Sampling Method:   Probability Sample
Study Population
Gestational participants without HPV infection
Criteria

Inclusion Criteria:

  • Those are aged 20 to 45 years old, have vaginal intercourse more than 3 years, and aren't in menstrual, pregnancy or puerperium period.

Exclusion Criteria:

  • Those are aged more than 45 years old without HPV infection in the last one year, having no vaginal intercourse, and those can't cooperate the examiner. Women who are HIV or hepatitis B/C positive, have autoimmune disorders and systemic disease (like diabetes mellitus, hormone treatment diseases, severe liver and kidney dysfunction), or have severe mental illness and malignant tumors are also excluded. At the same time, all the participants should meet the following requirements: no vagina douching within last 2 days, no vaginal intercourse within last 3 days, no systemic application of antifungal agents or antibiotics or pessaries within last 14 days of sampling.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03786588


Contacts
Layout table for location contacts
Contact: Shu Wang +86-18810535568 chaoxp_pumch@163.com

Locations
Layout table for location information
China, Beijing
Peking Union Medical College Hospital Recruiting
Beijing, Beijing, China, 100730
Contact: Hui Xu    +86-010-69156874      
Sponsors and Collaborators
Peking Union Medical College Hospital
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Layout table for additonal information
Responsible Party: shuwang, Associate Professor, Peking Union Medical College Hospital
ClinicalTrials.gov Identifier: NCT03786588    
Other Study ID Numbers: CPPVM
First Posted: December 26, 2018    Key Record Dates
Last Update Posted: August 29, 2019
Last Verified: August 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Pelvic Pain
Pain
Neurologic Manifestations